DE69941966D1 - Mittel und Verfahren zum Schutz, zur Behandlung und Reparatur von Bindegewebe - Google Patents

Mittel und Verfahren zum Schutz, zur Behandlung und Reparatur von Bindegewebe

Info

Publication number
DE69941966D1
DE69941966D1 DE69941966T DE69941966T DE69941966D1 DE 69941966 D1 DE69941966 D1 DE 69941966D1 DE 69941966 T DE69941966 T DE 69941966T DE 69941966 T DE69941966 T DE 69941966T DE 69941966 D1 DE69941966 D1 DE 69941966D1
Authority
DE
Germany
Prior art keywords
repair
treatment
protection
methods
connective tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69941966T
Other languages
English (en)
Inventor
Todd R Henderson
Barbara E Corson
Tarek Hammad
Medat Soliman
Louis Lippiello
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nutramax Laboratories Inc
Original Assignee
Nutramax Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutramax Laboratories Inc filed Critical Nutramax Laboratories Inc
Application granted granted Critical
Publication of DE69941966D1 publication Critical patent/DE69941966D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Reinforced Plastic Materials (AREA)
  • Inorganic Insulating Materials (AREA)
DE69941966T 1998-02-13 1999-02-12 Mittel und Verfahren zum Schutz, zur Behandlung und Reparatur von Bindegewebe Expired - Lifetime DE69941966D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7459498P 1998-02-13 1998-02-13

Publications (1)

Publication Number Publication Date
DE69941966D1 true DE69941966D1 (de) 2010-03-11

Family

ID=22120420

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69941966T Expired - Lifetime DE69941966D1 (de) 1998-02-13 1999-02-12 Mittel und Verfahren zum Schutz, zur Behandlung und Reparatur von Bindegewebe
DE69938036T Expired - Lifetime DE69938036D1 (de) 1998-02-13 1999-02-12 Mittel und verfahren zum schutz, zur behandlung und zur reparatur von bindegewebe

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69938036T Expired - Lifetime DE69938036D1 (de) 1998-02-13 1999-02-12 Mittel und verfahren zum schutz, zur behandlung und zur reparatur von bindegewebe

Country Status (12)

Country Link
EP (2) EP1917966B1 (de)
JP (1) JP2002502881A (de)
AT (2) ATE394108T1 (de)
AU (1) AU764431B2 (de)
CA (1) CA2320202C (de)
CY (1) CY1108110T1 (de)
DE (2) DE69941966D1 (de)
DK (2) DK1917966T3 (de)
ES (2) ES2338946T3 (de)
HK (1) HK1120211A1 (de)
PT (2) PT1917966E (de)
WO (1) WO1999040926A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6656925B2 (en) * 1998-09-09 2003-12-02 Advanced Medical Instruments Composition and method of treating arthritis
DE10054257A1 (de) * 2000-11-02 2002-05-16 Kief Horst Heilmittel zur Intraarticulären Injektion
FR2842738B1 (fr) * 2002-07-23 2006-02-10 Negma Lerads Utilisation d'une rheine pour la preparation d'un medicament pour le traitement de l'inflammation chronique, la prevention et le traitement du rejet des transplantations d'organes et de tissus
US20050090551A1 (en) * 2003-10-27 2005-04-28 Board Of Trustees Of Southern Illinois University Therapeutic use of methionine for the treatment or prevention of mucositis
CN101141968A (zh) * 2003-11-24 2008-03-12 浩鼎生技公司 给予化合物治疗哺乳动物的病况及其应用方法
MX2007011931A (es) * 2007-09-26 2009-03-26 World Trade Imp Export Wtie Ag Composicion farmaceutica que comprende la combinacion de un agente antiartritico y un agente inhibidor de la interleucina-1, util para el control y tratamiento de la osteoartritis y enfermedades relacionadas.
US8455436B2 (en) 2010-12-28 2013-06-04 Depuy Mitek, Llc Compositions and methods for treating joints
US8398611B2 (en) 2010-12-28 2013-03-19 Depuy Mitek, Inc. Compositions and methods for treating joints
EP2688481B1 (de) * 2011-03-25 2021-06-16 Trackside Technologies Pty Ltd Eine zubereitung enthaltend einen proinflammatorischen zytokinhemmer, epigallocatechingallat und ein nichtsteriodales antirheumatikum zur behandlung einer sehnenverletzung bei einem leistungstier, welches ein pferd ist.
US11000533B2 (en) 2011-03-25 2021-05-11 Trackside Technologies Pty Ltd. Connective tissue monitoring, compositions for connective tissue treatment and methods for treating connective tissue
US9682099B2 (en) 2015-01-20 2017-06-20 DePuy Synthes Products, Inc. Compositions and methods for treating joints
US20230248808A1 (en) * 2020-01-29 2023-08-10 Lonza Greenwood Llc Joint Health Composition and Use Thereof in Healthy Mammals
WO2024018956A1 (ja) * 2022-07-19 2024-01-25 サントリーホールディングス株式会社 経口組成物、及び、エルゴチオネイン又はその塩に由来する苦味及びコンドロイチン硫酸又はその塩に由来する臭みを抑制する方法
WO2024018955A1 (ja) * 2022-07-19 2024-01-25 サントリーホールディングス株式会社 経口組成物、及び、エルゴチオネインに由来する苦味及びグルコサミン類化合物に由来する異味を抑制する方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB856493A (en) * 1957-10-04 1960-12-21 Pfizer & Co C Therapeutic compositions comprising tetracycline antibiotics
FR2193M (fr) * 1962-09-10 1963-12-09 Lipha Nouveau médicament pour le traitement des maladies infectieuses.
US4704383A (en) * 1983-12-29 1987-11-03 The Research Foundation Of State University Of New York Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same
US4925833A (en) * 1983-12-29 1990-05-15 The Research Foundation Of State University Of New York Use of tetracycline to enhance bone protein synthesis and/or treatment of osteoporosis
GB8507058D0 (en) * 1985-03-19 1985-04-24 Efamol Ltd Pharmaceutical & dietary compositions
JPS63203628A (ja) * 1987-02-19 1988-08-23 Taiyo Kagaku Co Ltd 動物の乳房炎治療剤
US5770209A (en) * 1991-08-30 1998-06-23 University Of South Florida Acceleration of wound healing using connective tissue growth factor
US5258371A (en) * 1992-05-29 1993-11-02 Kuraray Co., Ltd. Method to reduce connective tissue destruction
US5364845C1 (en) * 1993-03-31 2002-09-10 Nutramax Lab Inc Glusosamine chondroitin and manganese composition for the protection and repair of connective tissue
FR2707087B1 (fr) * 1993-06-28 1995-10-13 Bioxytech Nouveau procédé de préparation de l'ergothionéine.
GB9403857D0 (en) * 1994-03-01 1994-04-20 Scotia Holdings Plc Fatty acid derivatives
JPH09143492A (ja) * 1995-11-17 1997-06-03 Katsumasa Koike 酸化脂質の確認方法及び酸化脂質の生成方法
NL1003503C2 (nl) * 1996-07-04 1998-01-07 Negma Steba International Dev Farmaceutische samenstelling voor orale toediening.
IT1288257B1 (it) * 1996-11-29 1998-09-11 Paoli Ambrosi Gianfranco De Composizione per uso cosmetico,farmaceutico o dietetico a base di un aminozucchero e/o di un acido poliidrossilico

Also Published As

Publication number Publication date
ES2302373T3 (es) 2008-07-01
EP1917966B1 (de) 2010-01-20
JP2002502881A (ja) 2002-01-29
PT1917966E (pt) 2010-03-17
EP1053000B1 (de) 2008-05-07
EP1053000A4 (de) 2003-01-29
ATE394108T1 (de) 2008-05-15
HK1120211A1 (en) 2009-03-27
CY1108110T1 (el) 2014-02-12
DK1053000T3 (da) 2008-09-01
CA2320202A1 (en) 1999-08-19
DE69938036D1 (de) 2008-03-13
EP1053000A1 (de) 2000-11-22
WO1999040926A1 (en) 1999-08-19
AU2674099A (en) 1999-08-30
ES2338946T3 (es) 2010-05-13
EP1917966A1 (de) 2008-05-07
CA2320202C (en) 2010-09-14
ATE455548T1 (de) 2010-02-15
AU764431B2 (en) 2003-08-21
DK1917966T3 (da) 2010-03-15
PT1053000E (pt) 2008-07-11

Similar Documents

Publication Publication Date Title
HK1120211A1 (en) Agents and methods for protection, treatment and repair of connective tissue
ATE455092T1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
DE69935345D1 (de) Methoden und zusammensetzungen zur prävention und behandlung der anämie
ATE250576T1 (de) Substituierte pyrrolylverbindungen zur behandlung von entzündungen
DE59807405D1 (de) Acylsulfamoylbenzoesäureamide, diese enthaltende nutzpflanzenschützende mittel und verfahren zu ihrer herstellung
ATE257385T1 (de) Zusammensetzungen und verfahren zur behandlung des erhöhten augenindruckes
ATE444086T1 (de) Therapeutische zusammensetzungen und verfahren zur behandlung von periodontitis mit entzündunshemmenden mitteln
DE60013266D1 (de) Steroidnitrate zur behandlung von oxidativen schädigungen und endothelialer dysfunktion
ATE362374T1 (de) Verfahren und zusammensetzungen zur prevention oder behandlung von krebs und von krebs assoziertem knochenverlust
ATE174786T1 (de) Orale präparate zur behandlung von plaque und gingivitis, die einen nicht-kationischen antibakteriellen wirkstoff und ein bikarbonatsalz enthalten
DE69405919D1 (de) Zusammensetzungen zur Behandlung von Keratinfasern
DE60033020D1 (de) Gerät zur behandlung von zahnkaries
ATE190843T1 (de) Zubereitungen zur behandlung von impotenz, die ein alpha-1 inhibitor und ein alpha-2 inhibitor enthalten
DE69808475D1 (de) Aminosäurederivate zur behandlung von schlaganfall
DE69913380D1 (de) Zusammensetzung zur behandlung von periodontalen erkrankungen
ATE292962T1 (de) Verwendung einer zusammensetzung zur herstellung eines arzneimittels zur vorbeugung und behandlung von parodontitis
DE69928501D1 (de) Mittel zur vorbeugung/behandlung von osteoporose
DE60000658D1 (de) Zusammensetzung zur behandlung von psoriasis
ATA93695A (de) Mittel zur behandlung von strahlenschäden
DE60141994D1 (de) 13-substituierte Methacyclinverbindungen
DE69808607D1 (de) Verfahren zur verwendung von cyclooxygenase-2 hemmern zur behandlung und vorbeugung der demenz
DE69921096D1 (de) Auf bibapcitide gegründete pharmaceutische zusammensetzungen für bildgebung und behandlung von thromben
DE69726037D1 (de) Zusammensetzung und Verfahren zur Behandlung von Kulturen gegen Bodenparasitärkomplexe
DE69833655D1 (de) Methoden und zusammensetzungen zur behandlung der hyperlipidämie

Legal Events

Date Code Title Description
8364 No opposition during term of opposition